Comparison With Conventional Therapies of Repeated Sirolimus-Eluting Stent Implantation for the Treatment of Drug-Eluting Coronary Stent Restenosis

American Journal of Cardiology

Volumn 98, Issue 11, 2006, Pages 1451-1454

  Kim, Young Hak ^a   Lee, Bong Ki ^a   Park, Duk Woo ^a   Park, Kyoung Ha ^a   Choi, Bong Ryong ^a   Lee, Cheol Whan ^a   Hong, Myeong Ki ^a   Kim, Jae Joong ^a   Park, Seong Wook ^a   Park, Seung Jung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CILOSTAZOL; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; SURVIVAL;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BRACHYTHERAPY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SIROLIMUS; STENTS;

EID: 33751193459     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.07.027     Document Type: Article

References (20)

1. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., et al., RAVEL Study Group. Randomized study with the sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
2. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., et al., SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
3. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., et al., TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
4. Kastrati A., Dibra A., Eberle S., Mehilli J., Suarez de Lezo J., Goy J.J., Ulm K., and Schomig A. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA 294 (2005) 819-825
5. Indolfi C., Pavia M., and Angelillo I.F. Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis). Am J Cardiol 95 (2005) 1146-1152
6. Kastrati A., Mehilli J., von Beckerath N., Dibra A., Hausleiter J., Pache J., Schuhlen H., Schmitt C., Dirschinger J., Schomig A., and ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293 (2005) 165-171
7. Lee S.W., Park S.W., Hong M.K., Lee J.H., Kim Y.H., Moon D.H., Oh S.J., Lee C.W., Kim J.J., and Park S.J. Comparison of angiographic and clinical outcomes between rotational atherectomy versus balloon angioplasty followed by radiation therapy with a rhenium-188-mercaptoacetyltriglycine-filled balloon in the treatment of diffuse in-stent restenosis. Int J Cardiol 102 (2005) 179-185
8. Park S.W., Hong M.K., Moon D.H., Oh S.J., Lee C.W., Kim J.J., and Park S.J. Treatment of diffuse in-stent restenosis with rotational atherectomy followed by radiation therapy with a rhenium-188-mercaptoacetyltriglycine-filled balloon. J Am Coll Cardiol 38 (2001) 631-637
9. Lee S.W., Park S.W., Hong M.K., Kim Y.H., Lee B.K., Song J.M., Han K.H., Lee C.W., Kang D.H., Song J.K., et al. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol 46 (2005) 1833-1837
10. Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., Pichard A.D., Kent K.M., Stone G.W., and Leon M.B. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
11. Mintz G.S., Nissen S.E., Anderson W.D., Bailey S.R., Erbel R., Fitzgerald P.J., Pinto F.J., Rosenfield K., Siegel R.J., Tuzcu E.M., and Yock P.G. ACC clinical expert consensus document on standards for the acquisition, measurement and reporting of intravascular ultrasound studies: a report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 37 (2001) 1478-1492
12. Hong M.K., Mintz G.S., Lee C.W., Park D.W., Park K.M., Lee B.K., Kim Y.H., Song J.M., Han K.H., Kang D.H., et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113 (2006) 414-419
13. Dawkins K.D., Grube E., Guagliumi G., Banning A.P., Zmudka K., Colombo A., Thuesen L., Hauptman K., Marco J., Wijns W., et al., TAXUS VI Investigators. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 112 (2005) 3306-3313
14. Iakovou I., Schmidt T., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., Michev I., et al. Angiographic patterns of restenosis after paclitaxel-eluting stent implantation. J Am Coll Cardiol 45 (2005) 805-806
15. Lemos P.A., Serruys P.W., van Domburg R.T., Saia F., Arampatzis C.A., Hoye A., Degertekin M., Tanabe K., Daemen J., Liu T.K., et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 109 (2004) 190-195
16. Ong A.T., Serruys P.W., Aoki J., Hoye A., van Mieghem C.A., Rodriguez-Granillo G.A., Valgimigli M., Sonnenschein K., Regar E., van der Ent M., et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol 45 (2005) 1135-1141
17. Lemos P.A., van Mieghem C.A., Arampatzis C.A., Hoye A., Ong A.T., McFadden E., Sianos G., van der Giessen W.J., de Feyter P.J., van Domburg R.T., and Serruys P.W. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes. Circulation 109 (2004) 2500-2502
18. Ortolani P., Marzocchi A., Aquilina M., Gaiba W., Neri S., Marrozzini C., Palmerini T., Taglieri N., and Branzi A. 32P brachytherapy in the treatment of complex Cypher in-stent restenosis. J Interv Cardiol 18 (2005) 205-211
19. Moussa I.D., Moses J.W., Kuntz R.E., Holmes D.R., Popma J.J., Teirstein P.S., Wong S.C., and Leon M.B. The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial). Am J Cardiol 97 (2006) 1582-1584
20. Fineschi M., Gori T., Pierli C., Casini S., Sinicropi G., Buti A., and Bravi A. Restenosis after sirolimus stent implantation: a rare but challenging condition. Data from real-world experience. (abstr). Am J Cardiol 96 suppl 7A (2005) 188H